Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - NEUROLOGIX INC/DE | y04676e10vk.htm |
| EX-23.1 - EX-23.1 - NEUROLOGIX INC/DE | y04676exv23w1.htm |
| EX-31.1 - EX-31.1 - NEUROLOGIX INC/DE | y04676exv31w1.htm |
| EX-31.2 - EX-31.2 - NEUROLOGIX INC/DE | y04676exv31w2.htm |
Exhibit 32.1
Certification
Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906
of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on
Form 10-K
of Neurologix, Inc., a Delaware corporation (the
“Company”), for the year ended
December 31, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”),
each of Clark A. Johnson as President and Chief Executive
Officer, and Marc L. Panoff, as Chief Financial Officer and
Treasurer of the Company, hereby certifies, pursuant to
18 U.S.C. § 1350, as adopted pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of his knowledge:
| (1) | The Report fully complies with the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
/s/ Clark
A. Johnson
Clark A. Johnson
President and Chief Executive Officer
March 25, 2011
/s/ Marc
L. Panoff
Marc L. Panoff
Chief Financial Officer and Treasurer
March 25, 2011
This certification accompanies the Report pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002 and shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002,
be deemed filed by the Company for purposes of § 18 of
the Securities Exchange Act of 1934, as amended.